 GERMANTOWN, Md., Jan. 6, 2021 PRNewswire -- Precigen, Inc. Nasdaq: PGEN, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will... 